{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:12:44Z","timestamp":1788581564246,"version":"build-2803163510"},"reference-count":48,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej26-0047","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:10:09Z","timestamp":1779228609000},"page":"1017-1026","source":"Crossref","is-referenced-by-count":0,"title":["Differentiating TRAb-positive painless thyroiditis from Graves\u2019 disease using biochemical and ultrasound findings"],"prefix":"10.1507","volume":"73","author":[{"given":"Yoshiki","family":"Furumura","sequence":"first","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-5786","authenticated-orcid":false,"given":"Mitsuru","family":"Ito","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Monno","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Miyamura","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Fukata","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijun","family":"Nishihara","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsushige","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[{"name":"Center for Excellence in Thyroid Care, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, et al. (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21: 593\u2013646.","DOI":"10.1089\/thy.2010.0417"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al. (2016) 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26: 1343\u20131421.","DOI":"10.1089\/thy.2016.0229"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Singer PA (1991) Thyroiditis. Acute, subacute, and chronic. Med Clin North Am 75: 61\u201377.","DOI":"10.1016\/S0025-7125(16)30472-2"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Sanders J, Evans M, Premawardhana LD, Depraetere H, Jeffreys J, et al. (2003) Human monoclonal thyroid stimulating autoantibody. Lancet 362: 126\u2013128.","DOI":"10.1016\/S0140-6736(03)13866-4"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, et al. (2004) Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14: 560\u2013570.","DOI":"10.1089\/1050725041692918"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Smith BR, Bolton J, Young S, Collyer A, Weeden A, et al. (2004) A new assay for thyrotropin receptor autoantibodies. Thyroid 14: 830\u2013835.","DOI":"10.1089\/1050725042451248"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kamijo K, Ishikawa K, Tanaka M (2005) Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 52: 525\u2013529.","DOI":"10.1507\/endocrj.52.525"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Yoshimura Noh J, Miyazaki N, Ito K, Takeda K, Hiramatsu S, et al. (2008) Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. Thyroid 18: 1157\u20131164.","DOI":"10.1089\/thy.2008.0119"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Taylor HC, Sheeler LR (1982) Recurrence and heterogeneity in painless thyrotoxic lymphocytic thyroiditis. Report of five cases. JAMA 248: 1085\u20131088.","DOI":"10.1001\/jama.248.9.1085"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Yamamoto M, Saito S, Sakurada T, Kaise K, Kaise N, et al. (1984) Changes in antimicrosomal antibody, serum thyroglobulin and thyrotropin binding inhibitor immunoglobulin in a patient with silent thyroiditis who experienced four thyrotoxic episodes. Nihon Naibunpi Gakkai Zasshi 60: 939\u2013949 (in Japanese).","DOI":"10.1507\/endocrine1927.60.8_939"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Jansson R, Bernander S, Karlsson A, Levin K, Nilsson G (1984) Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab 58: 681\u2013687.","DOI":"10.1210\/jcem-58-4-681"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Mitani Y, Shigemasa C, Kouchi T, Taniguchi S, Ueta Y, et al. (1992) Detection of thyroid-stimulating antibody in patients with inflammatory thyrotoxicosis. Horm Res 37: 196\u2013201.","DOI":"10.1159\/000182309"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Takasu N, Kamijo K, Sato Y, Yoshimura H, Nagata A, et al. (2004) Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves\u2019 disease. Clin Exp Pharmacol Physiol 31: 314\u2013319.","DOI":"10.1111\/j.1440-1681.2004.03991.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kamijo K (2003) TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto\u2019s thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr J 50: 113\u2013116.","DOI":"10.1507\/endocrj.50.113"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 McDougall IR (1990) The importance of obtaining thyroid uptake measurement in patients with hyperthyroidism. Nucl Med Commun 11: 73\u201376.","DOI":"10.1097\/00006231-199002000-00001"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16 Hiraiwa T, Ito M, Imagawa A, Isotani H, Takamatsu J, et al. (2004) High diagnostic value of a radioiodine uptake test with and without iodine restriction in Graves\u2019 disease and silent thyroiditis. Thyroid 14: 531\u2013535.","DOI":"10.1089\/1050725041517011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Yanagisawa T, Sato K, Kato Y, Shimizu S, Takano K (2005) Rapid differential diagnosis of Graves\u2019 disease and painless thyroiditis using total T3\/T4 ratio, TSH, and total alkaline phosphatase activity. Endocr J 52: 29\u201336.","DOI":"10.1507\/endocrj.52.29"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Frevert EU, Biester A, M\u00fcller MJ, Schmidt-Gayk H, von zur M\u00fchlen A, et al. (1994) Markers of bone metabolism during short-term administration of thyroxine in healthy volunteers. Eur J Endocrinol 131: 145\u2013149.","DOI":"10.1530\/eje.0.1310145"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Smith SR, Lovejoy JC, Rood J, Most M, Wickersham PJ, et al. (2003) The effects of triiodothyronine on bone metabolism in healthy ambulatory men. Thyroid 13: 357\u2013364.","DOI":"10.1089\/105072503321669848"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ito M, Takamatsu J, Yoshida S, Murakami Y, Sakane S, et al. (1997) Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves\u2019 disease. J Clin Endocrinol Metab 82: 616\u2013619.","DOI":"10.1210\/jcem.82.2.3751"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kasagi K, Kousaka T, Misaki T, Iwata M, Alam MS, et al. (1999) Comparison of serum thyrotrophin concentrations determined by a third generation assay in patients with various types of overt and subclinical thyrotoxicosis. Clin Endocrinol (Oxf) 50: 185\u2013189.","DOI":"10.1046\/j.1365-2265.1999.00632.x"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22 Amino N, Yabu Y, Miyai K, Fujie T, Azukizawa M, et al. (1978) Differentiation of thyrotoxicosis induced by thyroid destruction from Graves\u2019 disease. Lancet 2: 344\u2013346.","DOI":"10.1016\/S0140-6736(78)92943-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ishii H, Inada M, Tanaka K, Mashio Y, Naito K, et al. (1983) Induction of outer and inner ring monodeiodinases in human thyroid gland by thyrotropin. J Clin Endocrinol Metab 57: 500\u2013505.","DOI":"10.1210\/jcem-57-3-500"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ralls PW, Mayekawa DS, Lee KP, Colletti PM, Radin DR, et al. (1988) Color-flow Doppler sonography in Graves disease: \u201cthyroid inferno\u201d. AJR Am J Roentgenol 150: 781\u2013784.","DOI":"10.2214\/ajr.150.4.781"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ota H, Amino N, Morita S, Kobayashi K, Kubota S, et al. (2007) Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves\u2019 disease. Clin Endocrinol (Oxf) 67: 41\u201345.","DOI":"10.1111\/j.1365-2265.2007.02832.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Tozzoli R, Bagnasco M, Giavarina D, Bizzaro N (2012) TSH receptor autoantibody immunoassay in patients with Graves\u2019 disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. Autoimmun Rev 12: 107\u2013113.","DOI":"10.1016\/j.autrev.2012.07.003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Morita T, Tamai H, Oshima A, Mukuta T, Fukata S, et al. (1990) The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis. J Clin Endocrinol Metab 71: 1051\u20131055.","DOI":"10.1210\/jcem-71-4-1051"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kamijo K (2010) Study on cutoff value setting for differential diagnosis between Graves\u2019 disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement <i>via<\/i> the fully automated electrochemiluminescence immunoassay system. Endocr J 57: 895\u2013902.","DOI":"10.1507\/endocrj.K10E-199"},{"key":"29","unstructured":"29 Sheets RF (1955) The sequential occurrence of acute thyroiditis and thyrotoxicosis. J Am Med Assoc 157: 139\u2013140."},{"key":"30","doi-asserted-by":"publisher","unstructured":"30 Hasling C, Eriksen EF, Charles P, Mosekilde L (1987) Exogenous triiodothyronine activates bone remodeling. Bone 8: 65\u201369.","DOI":"10.1016\/8756-3282(87)90072-X"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Ross DS, Ardisson LJ, Meskell MJ (1989) Measurement of thyrotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay. J Clin Endocrinol Metab 69: 684\u2013688.","DOI":"10.1210\/jcem-69-3-684"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Wilkinson E, Rae PW, Thomson KJ, Toft AD, Spencer CA, et al. (1993) Chemiluminescent third-generation assay (Amerlite TSH-30) of thyroid-stimulating hormone in serum or plasma assessed. Clin Chem 39: 2167\u20132173.","DOI":"10.1093\/clinchem\/39.10.2167"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Franklyn JA, Black EG, Betteridge J, Sheppard MC (1994) Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. J Clin Endocrinol Metab 78: 1368\u20131371.","DOI":"10.1210\/jcem.78.6.8200938"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, et al. (1995) Interlaboratory\/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem 41: 367\u2013374.","DOI":"10.1093\/clinchem\/41.3.367"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Spencer CA, LoPresti JS, Nicoloff JT, Dlott R, Schwarzbein D (1995) Multiphasic thyrotropin responses to thyroid hormone administration in man. J Clin Endocrinol Metab 80: 854\u2013859.","DOI":"10.1210\/jcem.80.3.7883842"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, et al. (1981) Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves\u2019 disease and destruction-induced thyrotoxicosis. J Clin Endocrinol Metab 53: 113\u2013116.","DOI":"10.1210\/jcem-53-1-113"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Carl\u00e9 A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, et al. (2013) Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. Eur J Endocrinol 169: 537\u2013545.","DOI":"10.1530\/EJE-13-0533"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Salvatore D, Tu H, Harney JW, Larsen PR (1996) Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98: 962\u2013968.","DOI":"10.1172\/JCI118880"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Ito M, Toyoda N, Nomura E, Takamura Y, Amino N, et al. (2011) Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3&apos;-triiodothyronine-predominant Graves\u2019 disease. Eur J Endocrinol 164: 95\u2013100.","DOI":"10.1530\/EJE-10-0736"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Izumi Y, Hidaka Y, Tada H, Takano T, Kashiwai T, et al. (2002) Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves\u2019 thyrotoxicosis. Clin Endocrinol (Oxf) 57: 51\u201358.","DOI":"10.1046\/j.1365-2265.2002.01558.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Yoshimura Noh J, Momotani N, Fukada S, Ito K, Miyauchi A, et al. (2005) Ratio of serum free triiodothyronine to free thyroxine in Graves\u2019 hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. Endocr J 52: 537\u2013542.","DOI":"10.1507\/endocrj.52.537"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Hiraiwa T, Tsujimoto N, Tanimoto K, Terasaki J, Amino N, et al. (2013) Use of color Doppler ultrasonography to measure thyroid blood flow and differentiate graves\u2019 disease from painless thyroiditis. Eur Thyroid J 2: 120\u2013126.","DOI":"10.1159\/000350560"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Kashiwai T, Hidaka Y, Takano T, Tatsumi KI, Izumi Y, et al. (2003) Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves\u2019 disease. Endocr J 50: 45\u201349.","DOI":"10.1507\/endocrj.50.45"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Iitaka M, Morgenthaler NG, Momotani N, Nagata A, Ishikawa N, et al. (2004) Stimulation of thyroid-stimulating hormone (TSH) receptor antibody production following painless thyroiditis. Clin Endocrinol (Oxf) 60: 49\u201353.","DOI":"10.1111\/j.1365-2265.2004.01939.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Perloff WH (1956) Thyrotoxicosis following acute thyroiditis; a report of 5 cases. J Clin Endocrinol Metab 16: 542\u2013546.","DOI":"10.1210\/jcem-16-4-542"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Werner SC (1979) Graves\u2019 disease following acute (subacute) thyroiditis. Arch Intern Med 139: 1313\u20131315.","DOI":"10.1001\/archinte.1979.03630480085027"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Wartofsky L, Schaaf M (1987) Graves\u2019 disease with thyrotoxicosis following subacute thyroiditis. Am J Med 83: 761\u2013764.","DOI":"10.1016\/0002-9343(87)90910-7"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, et al. (1998) TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis. Clin Endocrinol (Oxf) 48: 445\u2013453.","DOI":"10.1046\/j.1365-2265.1998.00416.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ26-0047\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:38:25Z","timestamp":1788579505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ26-0047\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej26-0047","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ26-0047"}}